Browse by Basel Contributors ID
Jump to: 2008 2008Ginj, M. and Zhang, H. and Eisenwiener, K. P. and Wild, D. and Schulz, S. and Rink, H. and Cescato, R. and Reubi, J. C. and Maecke, H. R.. (2008) New pansomatostatin ligands and their chelated versions : affinity profile, agonist activity, internalization, and tumor targeting. Clinical cancer research, Vol. 14. pp. 2019-2027. Cescato, R. and Erchegyi, J. and Waser, B. and Piccand, V. and Maecke, H. R. and Rivier, J. E. and Reubi, J. C.. (2008) Design and in vitro characterization of highly sst2-selective somatostatin antagonists suitable for radiotargeting. Journal of Medicinal Chemistry, Vol. 51, H. 13. pp. 4030-4037. Breeman, W. A. and Fröberg, A. C. and de Blois, E. and van Gameren, A. and Melis, M. and de Jong, M. and Maina, T. and Nock, B. A. and Erion, J. L. and Mäcke, H. R. and Krenning, E. P.. (2008) Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides. Nuclear medicine and biology, Vol. 35, H. 8. pp. 839-849. Heppeler, A. and André, J. P. and Buschmann, I. and Wang, X. and Reubi, J. C. and Hennig, M. and Kaden, T. A. and Maecke, H. R.. (2008) Metal-ion-dependent biological properties of a chelator-derived somatostatin analogue for tumour targeting. Chemistry, a European journal, Vol. 14, H. 10. pp. 3026-3034. Velikyan, I. and Maecke, H. and Langstrom, B.. (2008) Convenient preparation of 68Ga-based PET-radiopharmaceuticals at room temperature. Bioconjugate chemistry, Vol. 19, H. 2. pp. 569-573. Abiraj, K. and Jaccard, H. and Kretzschmar, M. and Helm, L. and Maecke, H. R.. (2008) Novel DOTA-based prochelator for divalent peptide vectorization : synthesis of dimeric bombesin analogues for multimodality tumor imaging and therapy. Chemical Communications, 44 (28). pp. 3248-3250. Reubi, J. C. and Maecke, H. R.. (2008) Peptide-based probes for cancer imaging. Journal of nuclear medicine, Vol. 49, H. 11. pp. 1735-1738. Wild, D. and Mäcke, H. and Christ, E. and Gloor, B. and Reubi, J. C.. (2008) Glucagon-like peptide 1-receptor scans to localize occult insulinomas. The New England journal of medicine, Vol. 359, H. 7. pp. 766-768. Fani, M. and André, J. P. and Maecke, H. R.. (2008) 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals. Contrast media & molecular imaging, Vol. 3, H. 2. pp. 67-77. Cwikla, Jaroslaw B. and Mikolajczak, Renata and Pawlak, Dariusz and Buscombe, John R. and Nasierowska-Guttmejer, Anna and Bator, Andrzej and Maecke, Helmut R. and Walecki, Jerzy. (2008) Initial direct comparison of 99mTc-TOC and 99mTc-TATE in identifying sites of disease in patients with proven GEP NETs. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 49 (7). pp. 1060-1065. Forrer, Flavio and Riedweg, I. and Maecke, Helmut R. and Mueller-Brand, Jan. (2008) Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutica, 52 (4). pp. 334-340. Good, Stephan and Walter, Martin A. and Waser, Beatrice and Wang, Xuejuan and Müller-Brand, Jan and Béhé, Martin P. and Reubi, Jean-Claude and Maecke, Helmut R.. (2008) Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours. European Journal of Nuclear Medicine and Molecular Imaging, 35 (10). pp. 1868-1877. |